Mari-Lynn Drainoni, PhD, MEd
Research Professor
Boston University Chobanian & Avedisian School of Medicine
Infectious Diseases

PhD, Northeastern University
MEd, University of Massachusetts Boston
BA, Tufts University

Mari-Lynn Drainoni, M.Ed., Ph.D., is Research Professor in the Section of Infectious Diseases in the School of Medicine in the Chobanian and Avedisian School of Medicine and in the Department of Health Law, Policy & Management at the Boston University School of Public Health. She is also Co-Director of the Evans Center for Implementation and Improvement Sciences at Boston University. Dr. Drainoni's areas of expertise include the conduct of implementation research, qualitative research methods and mixed method studies with a focus on integrating research into practice. Her specific studies have focused on the content areas of infectious diseases, including HIV/AIDS and hepatitis C, as well as substance use, antibiotic prescribing and antibiotic stewardship, and integrating screening for social determinants of health into clinical practice. Dr. Drainoni has conducted numerous implementation studies to integrate research into practice, studies evaluating demonstration programs for at-risk populations, and mixed methods studies that include both surveys involving primary data collection and qualitative data collection and analysis. Some of her current research projects include: 1) an AHRQ-funded study evaluating alternative implementation strategies for antibiotic stewardship in two large inpatient hospital systems across the US; 2) a HRSA-funded study to implement and evaluate the use of community health workers to improve retention and outcomes in clinical care for persons living with HIV in 10 sites across the US; 3) a NIDA-funded study to examine police-led models of engaging people in treatment for opioid addiction in Massachusetts; 4) serving as the Implementation Science Core Director of the Healing Communities Study, a NIDA/SAMHSA-funded study in four states to implement and evaluate interventions designed to reduce overdose deaths; 5) an NHLBI-funded project to assess the implementation of a social determinants of health screening and referral intervention for children with sickle cell anemia; 6) a study of the uptake of rapid diagnostic tests for infectious disease and behavioral factors influencing use of rapid diagnostic tests; 7) an NICHD-funded study to test and implement an intervention designed to screen for social determinants of health and unmet material needs in pediatric practices across the US; 8) a VA-funded initiative to implement and evaluate a peer intervention for veterans leaving incarceration; 9) an American Cancer Society-funded study evaluating an intervention designed to improve offering the HPV vaccine in community health centers; and 10) leading the implementation science component of a PCORI-funded study to compare two brief interventions within the primary care medical home to assess the most effective strategy to improve outcomes among pregnant and postpartum women with depressive symptoms, assess the optimal time to deploy each strategy and examine the barriers to establishing these interventions. Dr. Drainoni also is the Implementation Science Lead on the Providence-Boston Center for AIDS Research (CFAR), Implementation Science Lead on the Lifespan/Brown Criminal Justice Research Program on Substance Use and HIV, and Principal Investigator on the Boston University School of Public Health NIDA-funded T32, Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE).

Diversity, Equity, Inclusion and Accessibility

As a woman, member of a sexual minority population and individual with a long family experience of physical and intellectual disabilities and mental illness, I am deeply committed to full equity, inclusion and access among diverse populations. As a first generation college student now in academia, I have always been intensely aware of the challenges I have faced to professional advancement in a field dominated by those without this barrier to overcome. This experience provided me with a heightened appreciation for those who have additional hills to climb. This has only strengthened my commitment to mentoring and the majority of my mentees have been women and/or individuals from historically underrepresented groups. My experiences have sensitized me to the importance of intentional and active listening and engagement with others from all groups in order to understand and appreciate their lived experience.

Prior to working in academia, I worked in mental health services with individuals living with substance use disorders, serious mental illness, physical disabilities and intellectual disabilities. This work, as well as the health challenges that have ravaged my family of origin, sensitized me to the critical role of circumstances in influencing future opportunities. All of my work since then has been focused in some ways on addressing social determinants of health.

As someone who climbed the ladder with limited formal support, my self-identified mentors – both personal and professional – have been crucial to my success. I embrace being a mentor, particularly for trainees who are first generation, women, or sexual and racial minorities. I have built mentoring into all of my work, including as MPI or co-investigator of two training programs, co-director of the Evans Center for Implementation and Improvement Sciences, or as senior faculty. I believe I am a consistent and thoughtful mentor and will do whatever is needed to ensure that my trainees can succeed in the arena of their choice. I also try to be a strong mentor for my staff, advocating for their support, development and advancement. As a researcher, I have ensured that study participants are approached and treated with respect, openness and understanding. I work to ensure that my work addresses health disparities and moves us towards health equity.

In summary, as someone who has greatly benefitted from opportunities that have been provided to me, I am firmly committed to diversity, equity and inclusive access as a core value of both my professional and personal life.

Research Professor
Boston University School of Public Health
Health Law, Policy & Management

Boston University
Evans Center for Implementation & Improvement Sciences

Boston University
Evans Center for Interdisciplinary Biomedical Research

Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices
07/20/2017 - 01/31/2023 (PI of Sub-Project / SP)
Boston Medical Center Corporation NIH NICHD

Integrated Care for Addiction, HIV and HCV Research and Education (ICAHRE)
07/01/2017 - 06/30/2022 (Multi-PI)
PI: Mari-Lynn Drainoni, PhD, MEd
NIH/National Institute on Drug Abuse

Improving Outcomes for Low-Income Mothers with Depression: A Comparative Effectiveness Trial of Two Care C
05/01/2017 - 12/31/2021 (PI of Sub-Project / SP)
Boston Medical Center Corporation Patient-Cnt.Out. Res

Evaluating the Effectiveness of Alternative Implementation Strategies for Antibiotic Stewardship: a Mixed Methods Study
05/01/2017 - 04/30/2021 (PI of Sub-Project / SP)
University of Utah HHS AHRQ

Personnel agreement for research services of Mari-Lynn Drainoni
10/01/2019 - 09/30/2020 (PI)
Department of Veterans Administration, Bedford

PrEPception: expanding Assisted reproduction options for serodiscordant couples
06/04/2015 - 06/03/2020 (Subcontract PI)
Boston Medical Center Corporation Gilead Sciences, Inc

The Lifespan/Brown Criminal Justice Research Program on Substance Use and HIV
01/01/2019 - 12/31/2019 (Subcontract PI)
The Miriam Hospital NIH NIDA

Improving Provider HPV Vaccine Conversations Through Education and Training
01/01/2016 - 12/31/2019 (Subcontract PI)
Boston Medical Center Corporation Amer Cancer Society

Personnel agreement for research services of Mari-Lynn Drainoni
09/30/2015 - 05/31/2019 (PI)
Department of Veterans Administration, Bedford

Training in Health Services Research for Vulnerable Populations
07/01/2017 - 06/30/2018 (Subcontract PI)
Boston Medical Center Corporation DHHS

Showing 10 of 33 results. Show All Results

Improving Chronic Disease Outcomes Across the Lifespan by Addressing Structural Racism
09/23/2022 - 06/30/2027 (PI)
University of Massachusetts Medical School / UMASS National Institute o

The Lifespan/Brown Criminal Justice Research Program on Substance Use and HIV
02/01/2020 - 12/31/2024 (PI)
The Miriam Hospital National Institute o

Implementing a Social Determinants of Health Screening and Referral Care Model in the Neonatal Intensive Care Unit
09/01/2022 - 08/31/2024 (PI)
University of Massachusetts Medical School / UMASS National Institute o

Addressing alcohol use related health disparities: A hybrid-effectiveness implementation study of a culturally adapted Motivational Interview for Latinx alcohol and drug users
02/01/2022 - 06/30/2024 (PI)
Boston University Department of Health

CAB-RPV LA Implementation Strategies Among High-Risk Populations
03/16/2021 - 06/30/2024 (PI)
ViiV Healthcare

Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices
07/21/2022 - 01/31/2024 (PI)
Umass Memorial Medical Center National Institute o

Broad Implementation of Outpatient Stewardship (BIOS) Study
02/01/2020 - 01/31/2024 (PI)
Childrens Hospital of Philadelphia Patient-Centered Out

Qualitative Interviews for VIRUS COVID-19 Registry Sites
03/30/2021 - 01/31/2023 (PI)
Society of Critical Care Medicine

Police-Led Opioid Intervention Programs: A Qualitative Examination of Program Models and Participant Experiences
05/01/2020 - 04/30/2021 (PI)
Brandeis University National Institute o


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Cohen RT, Burrowes SAB, Williams CJ, Neri CM, Klings ES, Jones KC, Walkey AJ, Drainoni ML. SNAP: Supportive non-invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team. Pediatr Blood Cancer. 2024 Jun 19; e31142.View Related Profiles. PMID: 38896013
  2. Samet JH, El-Bassel N, Winhusen TJ, Jackson RD, Oga EA, Chandler RK, Villani J, Freisthler B, Adams J, Aldridge A, Angerame A, Babineau DC, Bagley SM, Baker TJ, Balvanz P, Barbosa C, Barocas J, Battaglia TA, Beard DD, Beers D, Blevins D, Bove N, Bridden C, Brown JL, Bush HM, Bush JL, Caldwell R, Calver K, Calvert D, Campbell ANC, Carpenter J, Caspar R, Chassler D, Chaya J, Cheng DM, Cunningham CO, Dasgupta A, David JL, Davis A, Dean T, Drainoni ML, Eggleston B, Fanucchi LC, Feaster DJ, Fernandez S, Figueroa W, Freedman DA, Freeman PR, Freiermuth CE, Friedlander E, Gelberg KH, Gibson EB, Gilbert L, Glasgow L, Goddard-Eckrich DA, Gomori S, Gruss DE, Gulley J, Gutnick D, Hall ME, Harger Dykes N, Hargrove SL, Harlow K, Harris A, Harris D, Helme DW, Holloway J, Hotchkiss J, Huang T, Huerta TR, Hunt T, Hyder A, Ingram VL, Ingram T, Kauffman E, Kimball JL, Kinnard EN, Knott C, Knudsen HK, Konstan MW, Kosakowski S, Larochelle MR, Leaver HM, LeBaron PA, Lefebvre RC, Levin FR, Lewis N, Lewis N, Lofwall MR, Lounsbury DW, Luster JE, Lyons MS, Mack A, Marks KR, Marquesano S, Mauk R, McAlearney AS, McConnell K, McGladrey ML, McMullan J, Miles J, Munoz Lopez R, Nelson A, Neufeld JL, Newman L, Nguyen TQ, Nunes EV, Oller DA, Oser CB, Oyler DR, Pagnano S, Parran TV, Powell J, Powers K, Ralston W, Ramsey K, Rapkin BD, Reynolds JG, Roberts MF, Robertson W, Rock P, Rodgers E, Rodriguez S, Rudorf M, Ryan S, Salsberry P, Salvage M, Sabounchi N, Saucier M, Savitzky C, Schackman B, Schady E, Seiber EE, Shadwick A, Shoben A, Slater MD, Slavova S, Speer D, Sprunger J, Starbird LE, Staton M, Stein MD, Stevens-Watkins DJ, Stopka TJ, Sullivan A, Surratt HL, Sword Cruz R, Talbert JC, Taylor JL, Thompson KL, Vandergrift N, Vickers-Smith RA, Vietze DJ, Walker DM, Walley AY, Walters ST, Weiss R, Westgate PM, Wu E, Young AM, Zarkin GA, Walsh SL. Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths. N Engl J Med. 2024 Jun 16.View Related Profiles. PMID: 38884347
  3. Knudsen HK, Walker DM, Mack N, Kinnard EN, Huerta TR, Glasgow L, Gilbert L, Garner BR, Dasgupta A, Chandler R, Walsh SL, Tin Y, Tan S, Sprunger J, Sprague-Martinez L, Salsberry P, Saucier M, Rudorf M, Rodriguez S, Oser CB, Oga E, Nakayima J, Linas BS, Lefebvre RC, Kosakowski S, Katz RE, Hunt T, Holman A, Holloway J, Goddard-Eckrich D, Fareed N, Christopher M, Aldrich A, Adams JW, Drainoni ML. Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (helping end addiction long-term®) communities study. Prev Med. 2024 Jun 08; 185:108034. PMID: 38857770
  4. Silver SR, Jones KC, Hook K, Crable EL, George ER, Serwint JR, Austad K, Walkey A, Drainoni ML. Defining the transition from new to normal: a qualitative investigation of the clinical change process. Res Sq. 2024 May 21.View Related Profiles. PMID: 38826210; PMCID: PMC11142356; DOI: 10.21203/;
  5. Rudel RK, Byhoff E, Fielman SB, Strombotne KL, Drainoni ML, Greece JA. A Qualitative Study of A Health Center-Based Mobile Produce Market. J Ambul Care Manage. 2024 Jul-Sep 01; 47(3):134-142.View Related Profiles. PMID: 38771169
  6. Fletcher L, Burrowes S, Sabin LL, McCann N, Khan GK, Ruiz-Mercado G, Johnson S, Kimmel SD, Pierre C, Drainoni ML. Long-Acting Injectable ART in Practice: A Mixed Methods Implementation Study Assessing the Feasibility of Using LAI ART in High Risk Populations and At Alternative Low Barrier Care Sites. AIDS Patient Care STDS. 2024 May; 38(5):221-229.View Related Profiles. PMID: 38656905; DOI: 10.1089/apc.2024.0048;
  7. Rudel RK, Byhoff E, Strombotne KL, Drainoni ML, Greece JA. Factors Associated With Uptake of an Open Access Health Center-Based Mobile Produce Market: A Case for Expanded Eligibility. J Acad Nutr Diet. 2024 Apr 12.View Related Profiles. PMID: 38615994
  8. Berk J, Frank HE, Drainoni ML. Locked in and left out: the "prison penalty" for implementation of evidence-based interventions. Implement Sci Commun. 2024 Apr 09; 5(1):36. PMID: 38594784; PMCID: PMC11005118; DOI: 10.1186/s43058-024-00573-0;
  9. Byhoff E, LeClair AM, Smith CN, Roy TK, Drainoni ML. Designing an implementation strategy to increase health-related social needs screening: Applying the PRISM framework in a resource-limited clinical setting. Transl Behav Med. 2024 Feb 23; 14(3):197-205. PMID: 37897404
  10. Assoumou SA, Bonilla HV, Vautour L, White C, Read Newcomb A, Kibbe D, Goldie J, Merrill A, Monahan M, Linas BP, Drainoni ML, Pierre CM, Graham R. A Communications Campaign to Build Confidence in Covid-19 Vaccines: The Boston Medical Center Experience. NEJM Catal Innov Care Deliv. 2024 Feb; 5(2).View Related Profiles. PMID: 38813133; PMCID: PMC11132119; DOI: 10.1056/CAT.23.0322;
Showing 10 of 232 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 230 publications over 29 distinct years, with a maximum of 28 publications in 2023


Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

801 Massachusetts Avenue, rm. 2014
Boston MA 02118
Google Map

Drainoni's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department